Alliancebernstein L.P. Aveo Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

  • $287 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$8.48 - $14.97 $10.3 Million - $18.2 Million
1,218,830 Added 977.8%
1,343,480 $20.1 Million
Q3 2022

Nov 15, 2022
BUY
$6.61 - $8.72 $823,936 - $1.09 Million
124,650 New
124,650 $1.03 Million
Q2 2021

Jul 30, 2021
SELL
$6.21 - $7.45 $155,250 - $186,250
-25,000 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$3.47 - $9.99 $86,750 - $249,750
25,000 New
25,000 $129,000

Others Institutions Holding AVEO

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About AVEO PHARMACEUTICALS, INC.

AVEO Quotes by TradingView
  • Ticker AVEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,676,000
  • Description
  • AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...
More about AVEO
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email